Generic Oral Liquid Dosage Forms

generic oral liquid dosage forms

January 2017  •  Catalog no. LDF333R  •  Price US $2,850

The generic oral liquid dosage form drug segment is a rapidly evolving and highly unpredictable environment that has been a challenge to decision makers attempting to map strategies for success in this segment. There are 323 distinct APIs for which there is at least one approved generic oral liquid dosage form ANDA. These 323 APIs account for 1,141 approved ANDAs. Including all approved doses, the current universe of generic oral liquid dosage forms consists of 1,361 unique solution, suspension and syrup products. These products are marketed and supplied by 289 companies. Competition among the various drug and therapeutic classes is uneven, with the top eight segments accounting for a disproportionate level of activity and revenue. Understanding the underlying factors affecting business performance is key to attaining financial targets.

Bar_Graph  Report Brochure (Download PDF)

Blue document  Report Order Form  (Download PDF)

 Click Here to Order Online


Generic Oral Liquid Dosage Forms – What You Will Learn

• Provides detailed analysis of generic drugs supplied in oral liquid dosage forms and assesses key market segments, market dynamics and potential product opportunities
• Presents the competitive picture for generic solutions, suspensions and syrups in two dozen drug classes
• Evaluates the importance of ANDA filing strategies and indirect ANDA acquisition on participant growth prospects
• Analyzes the impact of patents, exclusivity and litigation on participant market sector prospects
• Assesses the market presence and product position of the top twenty-four generic suppliers in the oral liquid dosage form segment
• Evaluates the impact of economic, technology, and regulatory factors

Generic Oral Liquid Dosage Forms – Summary of Contents

Executive Summary

The Market Opportunity

The Economics of Generic Drugs
Growth in Generics
Demand Drivers
Competitive Landscape

Generic Oral Liquid Dosage Forms – Growth Factors

Patents and Exclusivity
Litigation and First-to-File ANDA Strategies
Buying and Selling ANDAs

Generic OLDFs – Product Considerations

Formulation Factors
Specialty Dosage Forms
Reconstitutable Powders
Primary Packaging

Generic Oral Liquid Dosage Forms – Market Analysis

Therapeutic Class Analysis

Analyzes key Therapeutic Classes

Drug Classes

Includes more than sixty drug classes


Analyzes more than two dozen market segments

Market Factors

Regulatory Issues
Litigation Issues
Evolving ANDA Filing Strategies
The Role of CMOs
Healthcare Economics

Company Analysis